Detalhe da pesquisa
1.
Improved survival with ipilimumab in patients with metastatic melanoma.
N Engl J Med
; 363(8): 711-23, 2010 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-20525992
2.
Biological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Therapy of Melanoma.
Am J Clin Oncol
; 40(2): 207-213, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25286079
3.
Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma.
J Clin Oncol
; 23(35): 8992-9000, 2005 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-16260693
4.
GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses.
Oncoimmunology
; 5(4): e1101204, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27141383
5.
Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanoma.
Am J Clin Oncol
; 38(1): 61-7, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25616203
6.
Biodegradation characteristics of starch-polystyrene loose-fill foams in a composting medium.
Bioresour Technol
; 101(19): 7258-64, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20472424
7.
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered for 3 years as adjuvant therapy of stages II(T4), III, and IV melanoma.
J Immunother
; 32(6): 632-7, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19483646